Validation of Major Adverse Cardiovascular Events (MACE) in US Claims Databases

被引：0

作者：

Haynes, Kevin ^{[1
]}

Nezamzadeh, Melissa S. ^{[1
]}

Newcomb, Craig W. ^{[1
]}

Roy, Jason ^{[1
]}

Kite, Whitney ^{[1
]}

Carbonari, Dena M. ^{[1
]}

Cardillo, Serena ^{[1
]}

Hennessy, Sean ^{[1
]}

Freeman, Cristin P. ^{[1
]}

Holick, Crystal N. ^{[2
]}

Esposito, Daina B. ^{[2
]}

Strom, Brian L. ^{[3
]}

Vincent, Lo Re ^{[1
]}

机构：

[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[2] HealthCore, Wilmington, DE USA

[3] Rutgers State Univ, Rutgers Biomed & Hlth Sci, New Brunswick, NJ 08903 USA

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2014年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

734

引用

页码：394 / 395

页数：2

共 50 条

[21] Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
Ramon Marsal, Josep
Urreta-Barallobre, Iratxe
Ubeda-Carrillo, Marimar
Osorio, Dimelza
Lumbreras, Blanca
Lora, David
Fernandez-Felix, Borja M.
Oristrell, Gerard
Rodenas-Alesina, Eduard
Herrador, Lorena
Ballesteros, Monica
Zamora, Javier
Pijoan, Jose, I
Ribera, Aida
Ferreira-Gonzalez, Ignacio
TRIALS, 2022, 23 (01)
[22] Sample size requirement in trials that use the composite endpoint major adverse cardiovascular events (MACE): new insights
Josep Ramon Marsal
Iratxe Urreta-Barallobre
Marimar Ubeda-Carrillo
Dimelza Osorio
Blanca Lumbreras
David Lora
Borja M. Fernández-Felix
Gerard Oristrell
Eduard Ródenas-Alesina
Lorena Herrador
Mónica Ballesteros
Javier Zamora
Jose I. Pijoan
Aida Ribera
Ignacio Ferreira-González
Trials, 23
[23] Daylight saving time association with major adverse cardiovascular events (MACE): Does it matter where you live?
Rodriguez-Cortes, Francisco Jose
Jimenez-Hornero, Jorge E.
Jimenez-Pastor, Jose Manuel
Lopez-Coleto, Luna
Meira e Cruz, Miguel
Lopez-Soto, Pablo J.
JOURNAL OF SLEEP RESEARCH, 2024, 33
[24] Acute kidney injury (AKI) outcome, a predictor of long-term major adverse cardiovascular events (MACE)
Omotoso, Bolanle A.
Abdel-Rahman, Emaad M.
Xin, Wenjun
Ma, Jennie Z.
Scully, Kenneth W.
Arogundade, Fatiu A.
Balogun, Rasheed A.
CLINICAL NEPHROLOGY, 2016, 85 (01) : 1 - 11
[25] A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
Dong Huang
Huan Yang
He Yu
Ting Wang
Zhu Chen
Rong Yao
Zongan Liang
BMC Pulmonary Medicine, 22
[26] A prediction model for major adverse cardiovascular events (MACE) in patients with coronavirus disease 2019 (COVID-19)
Huang, Dong
Yang, Huan
Yu, He
Wang, Ting
Chen, Zhu
Yao, Rong
Liang, Zongan
BMC PULMONARY MEDICINE, 2022, 22 (01)
[27] Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
Chen, Dongqing
Untaru, Rossana
Stavropoulou, Glykeria
Assadi-Khansari, Bahador
Kelly, Conagh
Croft, Amanda J.
Sugito, Stuart
Collins, Nicholas J.
Sverdlov, Aaron L.
Ngo, Doan T. M.
JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
[28] Role of Copeptin as a Predictor of Major Adverse Cardiovascular Events (MACE) During Hospitalization on Acute Myocardial Infarction Patient
Wiratama, I. P. R. S.
Wasyanto, T.
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0F)
[29] Can machine learning augment clinician adjudication of events in cardiovascular trials? A case study of major adverse cardiovascular events (MACE) across CVRM trials
Lea, H.
Hutchinson, E.
Meeson, A.
Nampally, S.
Dennis, G.
Wallander, M.
Andersson, T.
Persson, A.
Johnston, S. C.
Weatherall, J.
Khan, F.
Khader, S.
EUROPEAN HEART JOURNAL, 2021, 42 : 3061 - 3061
[30] Cardiorespiratory Fitness and Incidence of Major Adverse Cardiovascular Events in US Veterans: A Cohort Study
Kokkinos, Peter F.
Faselis, Charles
Myers, Jonathan
Narayan, Puneet
Sui, Xuemei
Zhang, Jiajia
Lavie, Carl J.
Moore, Hans
Karasik, Pamela
Fletcher, Ross
MAYO CLINIC PROCEEDINGS, 2017, 92 (01) : 39 - 48

← 1 2 3 4 5 →